Vise Technologies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Buy
55,057
+27,134
+97% +$2.19M 0.05% 314
2026
Q1
$2.68M Hold
27,923
– – 0.05% 294
2025
Q4
$2.68M Buy
27,923
+7,797
+39% +$757K 0.05% 295
2025
Q3
$1.92M Sell
20,126
-5,073
-20% -$466K 0.07% 267
2025
Q2
$2.2M Buy
+25,199
New +$2.14M 0.09% 235
2024
Q4
$1.3M Buy
16,244
+4,169
+35% +$361K 0.11% 199
2024
Q3
$1.09M Buy
12,075
+3,844
+47% +$323K 0.14% 150
2024
Q2
$648K Buy
8,231
+920
+13% +$75.4K 0.11% 184
2024
Q1
$637K Sell
7,311
-686
-9% -$58.5K 0.13% 166
2023
Q4
$659K Buy
7,997
+1,612
+25% +$123K 0.14% 151
2023
Q3
$500K Sell
6,385
-459
-7% -$38.4K 0.12% 170
2023
Q2
$603K Buy
6,844
+495
+8% +$42.6K 0.15% 156
2023
Q1
$512K Buy
6,349
+1,870
+42% +$152K 0.13% 163
2022
Q4
$348K Buy
4,479
+1,512
+51% +$123K 0.11% 205
2022
Q3
$240K Sell
2,967
-332
-10% -$29.8K 0.09% 253
2022
Q2
$296K Buy
3,299
+1,192
+57% +$121K 0.11% 199
2022
Q1
$234K Buy
+2,107
New +$223K 0.09% 206

Other funds holding MDT

Vise Technologies's MDT Position: Q2 2026 in Review

Vise Technologies increased its Medtronic (MDT) stake by 97% in Q2 2026, buying an estimated $2.19M and bringing the position to 55,057 shares worth $4.31M. The position accounts for 0.05% of the portfolio, ranked #314.

Vise Technologies first reported a position in MDT in Q1 2022 and has held it in 17 quarters since. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vise Technologies held 55,057 shares of Medtronic worth $4.31M as of Q2 2026.
  • Vise Technologies bought 27,134 Medtronic shares in Q2 2026, an estimated $2.19M.
  • Medtronic made up 0.05% of Vise Technologies's portfolio in Q2 2026, its #314 holding.
  • Vise Technologies first reported a position in Medtronic in Q1 2022 and has held it in 17 quarters since.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.